Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Hematology
Description:
Welcome to today’s episode. Persistent blood abnormalities, such as ongoing anemia or unusual white cell counts, require careful evaluation by a hematologist. The process begins with a detailed medical history and physical examination, followed by targeted blood tests like complete blood counts and peripheral smears. If needed, further tests such as bone marrow biopsies or genetic studies may be ordered to identify the root cause. Throughout this process, hematologists consider both common and rare conditions, ensuring nothing is overlooked. Early and accurate diagnosis is key to guiding effective treatment and improving patient outcomes. If you or someone you know has unexplained blood test results, consulting a hematologist is an important next step. Thank you for listening.
See More Webinars @ Hidoc Webinars
1.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
2.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
3.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
4.
As pesticides and wildfires rise, kids with cancer need resources
5.
Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer
1.
Exploring the Potential of Bendamustine in Cancer Treatment
2.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
3.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
4.
Understanding Histiocytosis: Symptoms, Causes, and Treatment Options
5.
Environmental Carcinogen Avoidance in Precision Prevention
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Role of Platelets in Normal Blood Clotting
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
How Hematologists Evaluate Persistent Blood Abnormalities
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge